Results 11 to 20 of about 3,013 (168)

A Randomized, Open-Label Study to Assess Efficacy of Weekly Assumption of Cholecalciferol versus Calcifediol in Older Patients with Hypovitaminosis D

open access: yesGeriatrics, 2022
The aim of this single-center, open-label, randomized controlled study was to evaluate which formulation of vitamin D—between cholecalciferol and calcifediol—is most effective in the treatment of hypovitaminosis D in older adults.
Chukwuma Okoye   +9 more
doaj   +1 more source

Calcifediol: Mechanisms of Action

open access: yesNutrients, 2023
Due to its essential role in calcium and phosphate homeostasis, the secosteroid hormone calcitriol has received growing attention over the last few years. Calcitriol, like other steroid hormones, may function through both genomic and non-genomic mechanisms.
Simone Donati   +7 more
openaire   +3 more sources

Calcifediol in the management of vitamin D deficiency-related skeletal and extraskeletal diseases: overview and clinical cases

open access: yesDrugs in Context, 2023
As well as being essential for musculoskeletal health, vitamin D is involved in numerous other physiological processes. Poor vitamin D status is linked to a wide range of diseases, including cardiovascular disease, autoimmune conditions, pulmonary ...
Enrique Casado   +4 more
doaj   +1 more source

Vitamin D Deficiency in Obese Children Is Associated with Some Metabolic Syndrome Components, but Not with Metabolic Syndrome Itself

open access: yesMetabolites, 2023
Vitamin D deficiency in children is a common nutritional issue in many populations worldwide, associated not only with skeletal malformations but, as recent studies suggest, also with the development of obesity and metabolic syndrome.
Jagoda Hofman-Hutna   +4 more
doaj   +1 more source

Rapid Nontranscriptional Effects of Calcifediol and Calcitriol

open access: yesNutrients, 2022
Classically, a secosteroid hormone, vitamin D, has been implicated in calcium and phosphate homeostasis and has been associated with the pathogenesis of rickets and osteomalacia in patients with severe nutritional vitamin D deficiency. The spectrum of known vitamin D-mediated effects has been expanded in recent years.
Simone Donati   +6 more
openaire   +3 more sources

Serum 25‐hydroxyvitamin D concentration and infectious respiratory disease complex in shelter dogs

open access: yesJournal of Veterinary Internal Medicine, 2021
Background Hypovitaminosis D is a risk factor for the development of respiratory infections in humans and repletion can be protective. Objectives Determine if serum 25‐hydroxyvitamin (OH)D concentrations are lower in shelter dogs and if 25(OH)D ...
Jared A. Jaffey   +8 more
doaj   +1 more source

Native vitamin D in pre-dialysis chronic kidney disease

open access: yesNefrología (English Edition), 2019
Chronic kidney disease patients have a high prevalence of vitamin D insufficiency/deficiency. Vitamin D deficiency has been associated with a variety of bone, metabolic and cardiovascular disorders.
Mariana P. Cardoso, Luciano A.L. Pereira
doaj   +3 more sources

Calcifediol for Use in Treatment of Respiratory Disease

open access: yesNutrients, 2022
Calcifediol is the prohormone of the vitamin D endocrine system (VDES). It requires hydroxylation to move to 1,25(OH)2D3 or calcitriol, the active form that exerts its functions by activating the vitamin D receptor (VDR) that is expressed in many organs, including the lungs. Due to its rapid oral absorption and because it does not require first hepatic
Marta Entrenas-Castillo   +3 more
openaire   +3 more sources

Calcifediol During Pregnancy Improves Maternal and Fetal Availability of Vitamin D Compared to Vitamin D3 in Rats and Modifies Fetal Metabolism

open access: yesFrontiers in Nutrition, 2022
The fetus depends on the transplacental transfer of vitamin D. Calcifediol (25-OH-D3) is the vitamin D metabolite that crosses the placenta. Previously, oral 25-OH-D3 improved serum 25-OH-D3 compared to vitamin D3 in non-pregnant subjects, although no ...
Antonio Gázquez   +6 more
doaj   +1 more source

Calcifediol supplementation to reduce pulse pressure in a limited sample of vitamin D deficient older adults with elevated parathyroid hormone levels

open access: yesClinical Nutrition Experimental, 2019
Summary: Vitamin D is proposed as an antihypertensive agent, but current evidence is inconclusive. Calcifediol is more potent in raising vitamin D status.
Pol Grootswagers   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy